NewGenIvf Group (NIVF) Competitors $0.45 -0.11 (-19.16%) Closing price 04:00 PM EasternExtended Trading$0.44 -0.01 (-3.20%) As of 05:16 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock NIVF vs. BRTX, MGRX, KDLY, SSY, OTRK, ATIP, ATPC, VSEE, BGLC, and DHACShould you be buying NewGenIvf Group stock or one of its competitors? The main competitors of NewGenIvf Group include BioRestorative Therapies (BRTX), Mangoceuticals (MGRX), Kindly MD (KDLY), SunLink Health Systems (SSY), Ontrak (OTRK), ATI Physical Therapy (ATIP), Agape ATP (ATPC), Vsee Health (VSEE), BioNexus Gene Lab (BGLC), and Digital Health Acquisition (DHAC). These companies are all part of the "healthcare" industry. NewGenIvf Group vs. BioRestorative Therapies Mangoceuticals Kindly MD SunLink Health Systems Ontrak ATI Physical Therapy Agape ATP Vsee Health BioNexus Gene Lab Digital Health Acquisition BioRestorative Therapies (NASDAQ:BRTX) and NewGenIvf Group (NASDAQ:NIVF) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, media sentiment, profitability, dividends, risk, analyst recommendations and community ranking. Does the MarketBeat Community believe in BRTX or NIVF? BioRestorative Therapies received 2 more outperform votes than NewGenIvf Group when rated by MarketBeat users. CompanyUnderperformOutperformBioRestorative TherapiesOutperform Votes2100.00% Underperform VotesNo VotesNewGenIvf GroupN/AN/A Is BRTX or NIVF more profitable? NewGenIvf Group has a net margin of 0.00% compared to BioRestorative Therapies' net margin of -2,697.08%. NewGenIvf Group's return on equity of 0.00% beat BioRestorative Therapies' return on equity.Company Net Margins Return on Equity Return on Assets BioRestorative Therapies-2,697.08% -98.49% -75.23% NewGenIvf Group N/A N/A N/A Do analysts rate BRTX or NIVF? BioRestorative Therapies currently has a consensus target price of $18.00, suggesting a potential upside of 943.48%. Given BioRestorative Therapies' stronger consensus rating and higher probable upside, analysts clearly believe BioRestorative Therapies is more favorable than NewGenIvf Group.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioRestorative Therapies 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00NewGenIvf Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Do insiders and institutionals have more ownership in BRTX or NIVF? 69.4% of BioRestorative Therapies shares are owned by institutional investors. Comparatively, 66.2% of NewGenIvf Group shares are owned by institutional investors. 25.5% of BioRestorative Therapies shares are owned by company insiders. Comparatively, 31.8% of NewGenIvf Group shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth. Does the media favor BRTX or NIVF? In the previous week, NewGenIvf Group had 2 more articles in the media than BioRestorative Therapies. MarketBeat recorded 9 mentions for NewGenIvf Group and 7 mentions for BioRestorative Therapies. NewGenIvf Group's average media sentiment score of 0.35 beat BioRestorative Therapies' score of 0.00 indicating that NewGenIvf Group is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioRestorative Therapies 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral NewGenIvf Group 2 Very Positive mention(s) 1 Positive mention(s) 6 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable earnings and valuation, BRTX or NIVF? NewGenIvf Group has higher revenue and earnings than BioRestorative Therapies. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioRestorative Therapies$377K34.34-$14.41M-$1.16-1.49NewGenIvf Group$5.14M0.47$130KN/AN/A Which has more risk & volatility, BRTX or NIVF? BioRestorative Therapies has a beta of 68.9, suggesting that its stock price is 6,790% more volatile than the S&P 500. Comparatively, NewGenIvf Group has a beta of 0.18, suggesting that its stock price is 82% less volatile than the S&P 500. SummaryNewGenIvf Group beats BioRestorative Therapies on 8 of the 15 factors compared between the two stocks. Remove Ads Get NewGenIvf Group News Delivered to You Automatically Sign up to receive the latest news and ratings for NIVF and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NIVF vs. The Competition Export to ExcelMetricNewGenIvf Grouphealth & allied services, not elsewhere classified IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.39M$1.96B$5.28B$7.07BDividend YieldN/A7.11%4.87%4.05%P/E RatioN/A15.1422.8717.48Price / Sales0.473.95357.3785.27Price / Cash3.119.3238.1634.64Price / Book0.214.066.233.79Net Income$130,000.00$87.49M$3.20B$247.10M7 Day Performance-51.76%-2.82%-7.91%-7.31%1 Month Performance-63.72%-5.41%-2.94%-10.19%1 Year PerformanceN/A-22.87%3.18%-7.40% NewGenIvf Group Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NIVFNewGenIvf Group0.8718 of 5 stars$0.45-19.2%N/AN/A$2.39M$5.14M0.00N/ANews CoverageGap UpHigh Trading VolumeBRTXBioRestorative Therapies3.3389 of 5 stars$1.78-1.7%$18.00+911.2%+37.4%$12.32M$377,000.00-1.167Gap UpMGRXMangoceuticals0.2543 of 5 stars$1.95-18.1%N/A-95.8%$10.08M$615,873.00-0.343Upcoming EarningsKDLYKindly MD0.6206 of 5 stars$1.61-15.3%N/AN/A$9.62M$2.88M-2.44N/AEarnings ReportNews CoverageGap UpSSYSunLink Health SystemsN/A$1.00-2.0%N/A+29.0%$7.04M$31.23M7.141,376Analyst ForecastNews CoverageOTRKOntrak2.034 of 5 stars$1.45-2.0%$45.00+3,003.4%-78.6%$6.12M$11.24M-0.14250News CoverageGap UpATIPATI Physical TherapyN/A$1.20+0.8%N/A-81.2%$5.29M$741.86M-0.065,600ATPCAgape ATP0.5532 of 5 stars$1.28+9.4%N/A-79.5%$5.11M$1.35M-1.7540Earnings ReportUpcoming EarningsNews CoverageGap UpVSEEVsee Health1.28 of 5 stars$1.20+7.1%$5.00+316.7%N/A$4.33M$6.38M0.00N/ABGLCBioNexus Gene LabN/A$0.24-5.5%N/A-51.5%$4.25M$9.26M0.0030Positive NewsGap DownDHACDigital Health AcquisitionN/A$1.12-8.2%N/A-90.7%$4.04MN/A0.002,021High Trading Volume Remove Ads Related Companies and Tools Related Companies BioRestorative Therapies Alternatives Mangoceuticals Alternatives Kindly MD Alternatives SunLink Health Systems Alternatives Ontrak Alternatives ATI Physical Therapy Alternatives Agape ATP Alternatives Vsee Health Alternatives BioNexus Gene Lab Alternatives Digital Health Acquisition Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NIVF) was last updated on 4/4/2025 by MarketBeat.com Staff From Our PartnersURGENT: Someone's Moving Gold Out of London...People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...Golden Portfolio | SponsoredFeds Just Admitted It—They Can Take Your CashThe Government Just Said Your Money Isn't Yours That's right—According to the DOJ, YOUR hard-earned money i...Priority Gold | SponsoredWarning: “DOGE Collapse” imminentElon Strikes Back You may already sense that the tide is turning against Elon Musk and DOGE. Just this week...Altimetry | SponsoredUrgent Bitcoin alert for RIGHT NOWFormer billion-dollar hedge fund manager Larry Benedict has released the most incredible presentation of his 4...Brownstone Research | SponsoredTrump’s Secret WeaponPlease don't wait—this is your moment to take action. Download your Wealth Protection Guide now, claim your fr...American Alternative | SponsoredTrump Makes Major Crypto AnnouncementTrump Ends the “War on Crypto” I expect it to pump the market, which is why I'm recommending ONE coin to al...Crypto 101 Media | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredYour Retirement Is Caught in the CrossfireWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewGenIvf Group Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share NewGenIvf Group With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy NIVF Stock Free NIVF Stock Alerts